Erschienen in:
01.09.2010 | Brief Report
Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia
verfasst von:
Uri S. Alon, René G. VanDeVoorde
Erschienen in:
Pediatric Nephrology
|
Ausgabe 9/2010
Einloggen, um Zugang zu erhalten
Abstract
We describe a child with familial hypocalciuric hypercalcemia (FHH) in whom the hypercalcemia seemed to interfere with tissue healing after tympanoplasty. Consequently, he was placed on cinacalcet (30 mg/day), changed after 2 weeks to 60 mg/day. The treatment resulted in a decrease in serum parathyroid hormone (PTH) from 148 to 32 pg/mL (normal 7–75) and ionized calcium from 1.48 to 1.23 mmol/L (1.13–1.34), as well as successful healing of the revised surgical scar. Over the 12-month treatment period no complications were noted. We conclude that cinacalcet may be considered a new, and currently the only, tool in treating children with symptomatic FHH.